share_log

Institutional Owners May Consider Drastic Measures as Shanghai GenTech Co., Ltd.'s (SHSE:688596) Recent CN¥460m Drop Adds to Long-term Losses

Institutional Owners May Consider Drastic Measures as Shanghai GenTech Co., Ltd.'s (SHSE:688596) Recent CN¥460m Drop Adds to Long-term Losses

機構投資者可能會考慮採取嚴厲措施,因爲正帆科技有限公司(SHSE:688596)最近的46000萬人民幣跌幅加劇了長期損失。
Simply Wall St ·  11/25 15:48

Key Insights

關鍵見解

  • Institutions' substantial holdings in Shanghai GenTech implies that they have significant influence over the company's share price
  • A total of 14 investors have a majority stake in the company with 51% ownership
  • 14% of Shanghai GenTech is held by insiders
  • 機構持有上海基因泰克的大量股權意味着它們對該公司的股價具有重大影響
  • 共有14名投資者擁有該公司的多數股權,擁有51%的所有權
  • 上海基因泰克14%的股份由內部人士持有

To get a sense of who is truly in control of Shanghai GenTech Co., Ltd. (SHSE:688596), it is important to understand the ownership structure of the business. We can see that institutions own the lion's share in the company with 35% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

要了解誰真正控制了上海基因泰克有限公司(SHSE: 688596),了解該業務的所有權結構非常重要。我們可以看到,機構擁有該公司的大部分股份,所有權爲35%。換句話說,該集團面臨最大的上行潛力(或下行風險)。

And institutional investors saw their holdings value drop by 4.5% last week. This set of investors may especially be concerned about the current loss, which adds to a one-year loss of 12% for shareholders. Also referred to as "smart money", institutions have a lot of sway over how a stock's price moves. Hence, if weakness in Shanghai GenTech's share price continues, institutional investors may feel compelled to sell the stock, which might not be ideal for individual investors.

上週,機構投資者的持股價值下降了4.5%。這組投資者可能特別擔心當前的虧損,這使股東一年的虧損增加了12%。也被稱爲 「智能貨幣」,機構對股票價格的走勢有很大的影響力。因此,如果上海基因泰克的股價持續疲軟,機構投資者可能會感到不得不出售該股票,這對於個人投資者來說可能並不理想。

Let's delve deeper into each type of owner of Shanghai GenTech, beginning with the chart below.

讓我們從下圖開始,深入研究上海基因泰克的每種所有者。

big
SHSE:688596 Ownership Breakdown November 25th 2024
SHSE: 688596 所有權明細 2024 年 11 月 25 日

What Does The Institutional Ownership Tell Us About Shanghai GenTech?

關於上海基因科技,機構所有權告訴我們什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構在向自己的投資者報告時通常會根據基準來衡量自己,因此,一旦股票被納入主要指數,他們通常會對股票更加熱情。我們預計大多數公司都會有一些機構在冊,尤其是在它們正在成長的情況下。

We can see that Shanghai GenTech does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Shanghai GenTech, (below). Of course, keep in mind that there are other factors to consider, too.

我們可以看到,上海基因泰克確實有機構投資者;他們持有該公司很大一部分股票。這意味着在這些機構工作的分析師已經看過這隻股票,他們很喜歡。但是就像其他人一樣,他們可能錯了。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌的情況並不少見。因此,值得檢查一下上海基因泰克過去的收益軌跡(見下文)。當然,請記住,還有其他因素需要考慮。

big
SHSE:688596 Earnings and Revenue Growth November 25th 2024
SHSE: 688596 2024 年 11 月 25 日收益和收入增長

Shanghai GenTech is not owned by hedge funds. Wind Holdings Limited is currently the largest shareholder, with 18% of shares outstanding. In comparison, the second and third largest shareholders hold about 9.3% and 3.1% of the stock.

上海基因泰克不歸對沖基金所有。Wind Holdings Limited目前是最大股東,已發行股份的18%。相比之下,第二和第三大股東持有約9.3%和3.1%的股份。

Looking at the shareholder registry, we can see that 51% of the ownership is controlled by the top 14 shareholders, meaning that no single shareholder has a majority interest in the ownership.

從股東登記冊來看,我們可以看到51%的所有權由前14名股東控制,這意味着沒有一個股東擁有所有權的多數股東。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

雖然研究公司的機構所有權可以爲您的研究增加價值,但研究分析師的建議以更深入地了解股票的預期表現也是一種好做法。有相當數量的分析師在報道該股,因此了解他們對未來的總體看法可能很有用。

Insider Ownership Of Shanghai GenTech

上海基因泰克的內部所有權

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

儘管內部人士的確切定義可能是主觀的,但幾乎每個人都認爲董事會成員是內部人士。管理層最終對董事會負責。但是,經理成爲執行委員會成員的情況並不少見,尤其是當他們是創始人或首席執行官時。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部所有權是一件好事。但是,在某些情況下,這使其他股東更難追究董事會對決策的責任。

It seems insiders own a significant proportion of Shanghai GenTech Co., Ltd.. It has a market capitalization of just CN¥9.8b, and insiders have CN¥1.3b worth of shares in their own names. That's quite significant. Most would be pleased to see the board is investing alongside them. You may wish to access this free chart showing recent trading by insiders.

看來內部人士擁有上海基因泰克有限公司的很大一部分股份。它的市值僅爲98元人民幣,內部人士以自己的名義持有價值13元人民幣的股票。這非常重要。大多數人會很高興看到董事會與他們一起投資。您不妨訪問這張顯示內部人士近期交易的免費圖表。

General Public Ownership

一般公有制

With a 34% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Shanghai GenTech. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

上海基因泰克擁有34%的所有權,主要由個人投資者組成的公衆對上海基因泰克有一定程度的影響力。儘管這種所有權規模可能不足以影響對他們有利的政策決定,但它們仍然可以對公司政策產生集體影響。

Private Company Ownership

私人公司所有權

Our data indicates that Private Companies hold 18%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我們的數據顯示,私營公司持有公司18%的股份。可能值得對此進行更深入的研究。如果關聯方,例如內部人士,對其中一傢俬營公司有興趣,則應在年度報告中予以披露。私營公司也可能在公司中擁有戰略利益。

Next Steps:

後續步驟:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - Shanghai GenTech has 4 warning signs (and 1 which can't be ignored) we think you should know about.

我覺得看看究竟誰擁有一家公司非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。以風險爲例,上海基因泰克有4個警告標誌(其中一個不容忽視),我們認爲你應該知道。

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

歸根結底,未來是最重要的。您可以訪問這份關於公司分析師預測的免費報告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件給編輯組(網址爲)simplywallst.com。
Simply Wall St 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論